id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-D-5408-0002,FDA,FDA-2023-D-5408,Reformulating Drug Products That Contain Carbomers Manufactured With Benzene; Guidance for Industry - Final Guidance,Other,Guidance,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2024-11-12T06:24:20Z,,1,0,090000648635c332
FDA-2023-D-5408-0001,FDA,FDA-2023-D-5408,Reformulating Drug Products That Contain Carbomers Manufactured With Benzene; Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2023-12-28T16:02:50Z,2023-28675,0,0,090000648636165e